Effect of manganese exposure on MPTP neurotoxicities

NeuroToxicology

Volumn 24, Issue 4-5, 2003, Pages 657-665

  Baek, Sun Yong ^a   Lee, Myong Jong ^a   Jung, Hyun Sil ^a   Kim, Hyun Ju ^a   Lee, Choong Ryeol ^b   Yoo, Cheolin ^b   Lee, Ji Ho ^b   Lee, Hun ^b   Yoon, Chung Sik ^c   Kim, Young Hoon ^d   Park, Jungsun ^e   Kim, Jae Woo ^f   Jeon, Beom S ^g   Kim, Yangho ^b  

^a Pusan National University School of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Catholic University of Daegu   (South Korea)

^d Inje University   (South Korea)

^e Korea Occupational Safety and Health Agency   (South Korea)

^f Dong A University   (South Korea)

^g Seoul National University Hospital   (South Korea)

Author keywords

Dopamine; Manganese; MPTP; Neurotoxicity; Parkinson disease

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 3,4 DIHYDROXYPHENYLACETIC ACID; DOPAMINE; DOPAMINE TRANSPORTER; GLIAL FIBRILLARY ACIDIC PROTEIN; HOMOVANILLIC ACID; MANGANESE; TYROSINE 3 MONOOXYGENASE;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ASTROCYTE; BLOOD LEVEL; CAUDATE NUCLEUS; CONFERENCE PAPER; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; ENVIRONMENTAL EXPOSURE; GLOBUS PALLIDUS; HYPERTROPHY; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NERVE CELL GROWTH; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PUTAMEN; SUBSTANTIA NIGRA; TISSUE LEVEL; TOXICOKINETICS;

ANIMALIA;

EID: 0041736030     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-813X(03)00033-0     Document Type: Conference Paper

References (38)

1. Ali MM, Murthy RC, Mandal SK, Chandra SV. Effect of low protein diet on manganese neurotoxicity. III. Brain neurotransmitter levels. Neurobehav Toxicol Teratol 1985;7:427-31.
2. Autissier N, Rochette L, Dumas P, Beley A, Loireau A, Bralet J. Dopamine and norepinephrine turnover in various regions of the rat brain after chronic manganese chloride administration. Toxicology 1982;24:175-82.
3. Baldwin S, Deaker M, Maher W. Low volume microwave digestion of marine biological tissues for the measurement of trace elements. Analyst 1994;119:1701-4.
4. Barbeau A. Manganese and extrapyramidal disorders (a critical review and tribute to Dr. George C. Cotzias). NeuroToxicology 1984;5:13-35.
5. Bonilla E, Prasad AL. Effects of chronic manganese intake on the levels of biogenic amines in rat brain regions. Neurobehav Toxicol Teratol 1984;6:341-4.
6. Bull RJ. Paradoxical decrease in corpus striatal manganese concentrations with manganese load. Commun Psychopharmacol 1978;2:17-20.
7. Calne DB, Chu NS, Huang CC, Lu CS, Olanow W. Manganism and idiopathic parkinsonism: similaritites and differences. Neurology 1994;44:1583-6.
8. Chandra SV, Shukla GS. Concentrations of striatal catecholamines in rats given manganese chloride through drinking water. J Neurochem 1981;36:683-7.
9. Chandra SV, Shukla GS, Saxena DK. Manganese-induced behavioral dysfunction and its neurochemical mechanism in growing mice. J Neurochem 1979;33:1217-21.
10. Council NR. Guide for the Care and Use of Laboratory Animals. Washington, DC: National Academy Press; 1996.
11. Daniel AJ, Gysling K, Abarca J. Uptake and release of manganese by rat striatal slices. Biochem Pharmacol 1981;30:1833-7.
12. Eriksson H, Lenngren S, Heilbronn E. Effect of long-term administration of manganese on biogenic amine levels in discrete striatal regions of rat brain. Arch Toxicol 1987;59:426-31.
13. Francois B, Oliver G, Josiane A, Francis P. Determination of manganese in biological materials by electrothermal atomic absorption spectrometry: a review. Clin Chem 1988;34:227-34.
14. Franklin KBJ, Paxinos G. The Mouse Brain in Stereotaxic Coordinates, first ed. London: Academic Press; 1997.
15. German DC, Nelson EL, Liang CL, Speciale SG, Sinton CM, Sonsalla PK. The neurotoxin MPTP causes degeneration of specific nucleus A8, A9 and A10 dopaminergic neurons in the mouse. Neurodegeneration 1996;5:299-312.
16. Gianutsos G, Murray MT. Alterations in brain dopamine and GABA following inorganic or organic manganese administration. Neurotoxicology 1982;3:75-81.
17. Gorell JM, Johnson CC, Rybicki BA, Peterson EL, Kortsha GX, Brown GG et al. Occupational exposures to metals as risk factors for Parkinson's disease. Neurology 1997;48:650-8.
18. Gorell JM, Johnson CC, Rybicki BA, Peterson EL, Kortsha GX, Brown GG et al. Occupational exposures to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson's disease. Neurotoxicology 1999;20:239-48.
19. Hong JS, Hung CR, Seth PK, Mason G, Bondy SC. Effect of manganese treatment on the levels of neurotransmitters, hormones, and neuropeptides: modulation by stress. Environ Res 1984;34:242-9.
20. Kim Y, Kim J, Ito K, Lim H-S, Cheong H-K, Kim JY et al. Idiopathic parkinsonism with superimposed manganese exposure: utility of positron emission tomography. Neurotoxicology 1999; 20:249-52.
21. Kim Y, Kim JM, Kim J, Yoo C, Lee C-R, Lee JH et al. Dopamine transporter density is decreased in parkinsonian patients with a history of manganese exposure: what does it mean? Mov Disord 2002;17:568-75.
22. Komura J, Sakamoto M. Effects of manganese forms on biogenic amines in the brain and behavioral alterations in the mouse: long-term oral administration of several manganese compounds. Environ Res 1992;57:34-44.
23. Lee CS, Sauer H, Bjorklund A. Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by intrastriatal 6-hydroxydopamine in the rat. Neuroscience 1996;72:641-53.
24. Liang C, Sinton CM, Sonsalla PK, German DC. Midbrain dopaminergic neurons in the mouse that contain calbindin-D28k exhibit reduced vulnerability to MPTP-induced neurodegeneration. Neurodegenration 1996;5:313-8.
25. Olanow CW, Good PF, Shinotoh H, Hewitt KA, Vingerhoets F, Snow BJ et al. Manganese intoxication in the rhesus monkey: a clinical, imaging, pathologic, and biochemical study. Neurology 1996;46:492-8.
26. Ríos C, Alvarez-Vega R, Rojas P. Depletion of copper and manganese in brain after MPTP treatment of mice. Pharmacol Toxicol 1995;76:348-52.
27. Rojas P, Ríos C. Short-term manganese pretreatment partially protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity. Neurochem Res 1995;10:1217-23.
28. 12 and EDTA treatment on tissue levels and urinary excretion of trace metals in rats. Arch Environ Contam Toxicol 1982;11:515-20.
29. Seidler A, Hellenbrand W, Robra B-P, Vieregge P, Nischan P, Joerg J et al. Possible environmental, occupational, and other etiological factors for Parkinson's disease: a case control study in Germany. Neurology 1996;46:1275-84.
30. Semchuk KM, Love EJ, Lee LG. Parkinson's disease: a test of the multifactorial etiologic hypothesis. Neurology 1993;43:1173-80.
31. Shinotoh H, Snow BJ, Chu NS, Huang CC, Lu CS, Lee C et al. Presynaptic and postsynaptic striatal dopaminergic function in patients with manganese intoxication: a positron emission tomography study. Neurology 1997;48:1053-5.
32. Shukla GS, Chandra SV. Manganese toxicity: lipid peroxidation in rat brain. Acta Pharmacol Toxicol 1981;48:95-100.
33. Shukla GS, Dubey MP, Chandra SV. Manganese-induced biochemical changes in growing versus adult rats. Arch Environ Contam Toxicol 1980;9:383-91.
34. Vieregge P, Heinzow B, Korf G, Teichert HM, Schleifenbaum P, Mosinger HU. Long term exposure to manganese in rural well water has no neurological effects. Can J Neurol Sci 1995;22:286-9.
35. Yamada M, Ohno S, Okayasu I, Okeda R, Hatakeyama S, Watanabe H et al. Chronic manganese poisoning: a neuropathological study with determination of manganese distribution in the brain. Acta Neuropathol 1986;70:273-8.
36. Yong VW, Perry TL, Godolphin WJ, Jones KA, Clavier RM, Ito M et al. Chronic organic manganese administration in the rat does not damage dopaminergic nigrostriatal neurons. Neurotoxicology 1986;7:19-24.
37. Zayed J, Ducic S, Campanella G, Panisset JC, Andre P, Masson H et al. Environmental factors in the etiology of Parkinson's disease. Can J Neurol Sci 1990;17:286-91.
38. Zigmond MJ, Abercrombie ED, Berger TW, Grace AA, Stricker EM. Compensations after lesions of central dopaminergic neurons - some clinical and basic implications. Trends Neurosci 1990;13:290-6.